Impact of ivermectin on illness and disability associated with onchocerciasis.
about
Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposureAfrican Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and costAfrican Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious DiseasesRiver blindness: a success story under threat?Ivermectin resistance in Onchocerca volvulus: toward a genetic basisThe geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.Ivermectin and onchocerciasis: is it all solved?New strategies to combat filariasis.Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.Efficacy of three-week oxytetracycline or rifampin monotherapy compared with a combination regimen against the filarial nematode Onchocerca ochengiAssessment of community's knowledge, attitude and practice about onchocerciasis and community directed treatment with Ivermectin in Quara District, north western Ethiopia.Characteristics of persons who complied with and failed to comply with annual ivermectin treatment.Intention to continue with ivermectin treatment for onchocerciasis control after eight years of annual distribution in Cameroon, Nigeria, and Uganda.Where would I be without ivermectin? Capturing the benefits of community-directed treatment with ivermectin in Africa.Challenges in drug discovery for novel antifilarials.Scientific sovereignty: how international drug donation programs reshape health, disease, and the state.Assessing the Impact of Vaccination on Controlling the Spread of Human Scabies
P2860
Q28471815-ADCAE4D3-2D67-4E8D-91D9-2A924ABBB639Q28485398-106AF98F-558A-4F58-9277-555804C42062Q28548420-414FAAE7-90B9-47D9-8FA0-D35EB7B26E2EQ33258476-B88EB253-0C7E-459B-A56B-375CE6A8F516Q33305360-7555DAE3-60C4-4646-BDE6-D8693849DDBAQ34465622-BF22D0FF-F269-4C4D-BA66-524363E5E2C2Q35183373-973F6102-F538-4F03-90B6-34F960A912FBQ35981907-FC5BD48D-6A9B-4950-AC5D-384E58665634Q36320403-D1824962-4DD1-48B2-A4B8-A191D77D9EB4Q36441491-7EA160ED-998E-4D26-BFA9-32DB0D6A589FQ37045287-2F271759-1B12-4337-A988-EAAAB2F664EDQ37544726-A7843028-69D8-48E2-8DB3-75E41B3A91CCQ37684493-9FB4EA9C-8604-412B-A7D4-30B67BE1F97CQ38867971-DAFA661D-91B3-4314-9A29-1C60D10C9903Q38868667-D3B96AF0-47D9-4847-8458-74DB6368EF05Q38870646-02627A88-F351-4C1E-BD0C-F959E027D604Q39531590-7CAAB773-0317-4616-8F57-63F07D22C32BQ48423471-B065CA4E-8CFA-4C7C-80A0-79416FA61FD5Q58994990-0AA5A4FA-978A-40B0-987C-A2A70DE0BC5B
P2860
Impact of ivermectin on illness and disability associated with onchocerciasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Impact of ivermectin on illness and disability associated with onchocerciasis.
@ast
Impact of ivermectin on illness and disability associated with onchocerciasis.
@en
type
label
Impact of ivermectin on illness and disability associated with onchocerciasis.
@ast
Impact of ivermectin on illness and disability associated with onchocerciasis.
@en
prefLabel
Impact of ivermectin on illness and disability associated with onchocerciasis.
@ast
Impact of ivermectin on illness and disability associated with onchocerciasis.
@en
P2860
P921
P1476
Impact of ivermectin on illness and disability associated with onchocerciasis.
@en
P2093
Arlyne Beeche
P2860
P304
P356
10.1111/J.1365-3156.2004.01213.X
P577
2004-04-01T00:00:00Z